Your browser doesn't support javascript.
loading
Loganetin protects against rhabdomyolysis-induced acute kidney injury by modulating the toll-like receptor 4 signalling pathway.
Li, Jie; Tan, Yu-Jun; Wang, Ming-Zhi; Sun, Ying; Li, Guang-Yan; Wang, Qi-Long; Yao, Jing-Chun; Yue, Jiang; Liu, Zhong; Zhang, Gui-Min; Ren, Yu-Shan.
Afiliação
  • Li J; Shandong New Time Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., Linyi, China.
  • Tan YJ; Center for New Drug Safety Evaluation of Lunan Pharmaceutical, Lunan Pharmaceutical Group Co., Ltd., Linyi, China.
  • Wang MZ; State Key Laboratory of Generic Manufacture Technology of Chinese Traditional Medicine, Lunan Pharmaceutical Group Co., Ltd., Linyi, China.
  • Sun Y; Shandong New Time Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., Linyi, China.
  • Li GY; Center for New Drug Safety Evaluation of Lunan Pharmaceutical, Lunan Pharmaceutical Group Co., Ltd., Linyi, China.
  • Wang QL; State Key Laboratory of Generic Manufacture Technology of Chinese Traditional Medicine, Lunan Pharmaceutical Group Co., Ltd., Linyi, China.
  • Yao JC; Shandong New Time Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., Linyi, China.
  • Yue J; Center for New Drug Safety Evaluation of Lunan Pharmaceutical, Lunan Pharmaceutical Group Co., Ltd., Linyi, China.
  • Liu Z; State Key Laboratory of Generic Manufacture Technology of Chinese Traditional Medicine, Lunan Pharmaceutical Group Co., Ltd., Linyi, China.
  • Zhang GM; Shandong New Time Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., Linyi, China.
  • Ren YS; Center for New Drug Safety Evaluation of Lunan Pharmaceutical, Lunan Pharmaceutical Group Co., Ltd., Linyi, China.
Br J Pharmacol ; 176(8): 1106-1121, 2019 04.
Article em En | MEDLINE | ID: mdl-30706443

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Substâncias Protetoras / Receptor 4 Toll-Like / Injúria Renal Aguda Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Substâncias Protetoras / Receptor 4 Toll-Like / Injúria Renal Aguda Idioma: En Ano de publicação: 2019 Tipo de documento: Article